Sudapack breaks ground on major PharmaGuard expansion in Erolzheim
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
Phase one of the expansion will convert an existing hall into an ISO 7-certified cleanroom for GMP-compliant production
The oral, film-coated tablet is licensed for patients whose cancer has returned during or shortly after hormone therapy
Soficitinib is a potent and selective TYK2 inhibitor under development for multiple T-cell mediated autoimmune disorders
This relates to the manufacture and supply of Human Recombinant Insulin (rh- Insulin) and Biosimilar Pegfilgrastim Drug Substance to the United States
Amrutanjan is also rolling out its new campaign, 'Har Dard Mitaye'
The audit was completed with zero critical and zero major observations
Subscribe To Our Newsletter & Stay Updated